An interventional study of Individualized Nursing Care in Diabetes Mellitus, Nursing Care and Self-care, sponsored by University of Yalova. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-08.
Sponsored by University of Yalova · Not applicable, Interventional, and Prevention
This randomized controlled trial aims to evaluate the effects of individualized nursing care interventions on self-efficacy, empowerment, and self-management behaviors in individuals diagnosed with diabetes. Diabetes requires lifelong management, and standard care approaches often fall short of meeting individual psychosocial and clinical needs. By implementing structured, patient-centered nursing care protocols, this study assesses how personalized education, follow-up, and support mechanisms influence patients' capacity to manage their condition, improve glycemic control, and enhance their overall quality of life.
Diabetes mellitus is a chronic metabolic condition that demands continuous daily self-care, dietary adherence, medication management, and regular monitoring to prevent long-term complications. Traditional clinical approaches are frequently standardized, which can limit their effectiveness in addressing the unique psychosocial, behavioral, and cultural needs of individual patients.
8,290 studies on the registry are indexed under Diabetes Mellitus; 1,077 are open to participants now.
This study's planned enrollment of 68 is below the median of 80 across 6,023 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →University of Yalova is the lead sponsor of 61 studies on the registry; 22 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receiving structured, individualized nursing care interventions and support protocols.
Behavioral: Individualized Nursing Care
Participants receiving standard routine clinical care.
Participants in this group receive structured, personalized nursing care sessions, including targeted education, individual goal-setting, self-monitoring guidance, and ongoing follow-up to enhance diabetes self-management.
Adult Diabetes Knowledge Score
Change in adult diabetes knowledge score as measured by the Adult Diabetes Knowledge Scale (ADKS) from baseline to 3 months. (Total score ranging from 0 to 28 points).
Time frame: Baseline and 3 months
Diabetes Self-Management Behaviors Score
Change in diabetes self-management score as measured by the Diabetes Self-Management Questionnaire (DSMQ) from baseline to 3 months. (Total and subscale points).
Time frame: Baseline and 3 months
Diabetes Empowerment and Psychosocial Self-Efficacy Score
Change in diabetes empowerment score as measured by the Diabetes Empowerment Scale (DES) from baseline to 3 months. (Likert scale points ranging from 0 to 5).
Time frame: Baseline and 3 months
Plan to share: Yes — Yes, de-identified participant data will be shared upon reasonable request to the corresponding author.
Supporting information: Study protocol, Informed consent form
Time frame: Available beginning 3 months following article publication and ending 5 years after publication.
Access criteria: Requests should be directed to the corresponding author via email. Access will be granted to researchers whose proposed use of the data has been approved by an independent review committee for individual participant meta-analyses.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Yalova